UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000048067 |
|---|---|
| Receipt number | R000054566 |
| Scientific Title | Patient Pathway, Burden and Priority in Life with Dedifferentiated Liposarcoma from the Perspectives of Patients and Their Care Partners in Japan |
| Date of disclosure of the study information | 2022/07/01 |
| Last modified on | 2022/12/15 19:15:42 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Patient Pathway, Burden and Priority in Life with Dedifferentiated Liposarcoma from the Perspectives of Patients and Their Care Partners in Japan
Acronym
Patient Pathway, Burden and Priority in Life with Dedifferentiated Liposarcoma in Japan
Scientific Title
Patient Pathway, Burden and Priority in Life with Dedifferentiated Liposarcoma from the Perspectives of Patients and Their Care Partners in Japan
Scientific Title:Acronym
Patient Pathway, Burden and Priority in Life with Dedifferentiated Liposarcoma in Japan
Region
| Japan |
Condition
Condition
Dedifferentiated liposarcoma
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To understand experiences of patients with dedifferentiated liposarcoma and their care partners and to identify burdens and priorities in life through their feelings, thoughts, and behaviours.
Basic objectives2
Others
Basic objectives -Others
Not applicable
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Demographics, symptoms and conditions, diagnosis and treatment history, burden of disease and treatment, burden of patient care support from others, access to information, liposarcoma disease awareness, future treatment, expectations of changes in life and social environment
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patient
Inclusion Criteria:
1) A patient with diagnosis of dedifferentiated liposarcoma
2) 18 years of age or older
Exclusion Criteria:
1) A patient judged as difficult to participate (be interviewed)in this study per treating physician (specialist)
Care partner
Inclusion criteria:
1) A family member, a relative or a partner who lives together
or regularly and constantly communicate with the patient who is eligible for this study and appointed by the patient
2) 18 years of age or older
Key exclusion criteria
None
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Nobutaka |
| Middle name | |
| Last name | Yagi |
Organization
Nippon Boehringer Ingelheim Co., Ltd.
Division name
Patient Engagement
Zip code
141-6017
Address
2-1-1 Osaki, Shinagawa-ku,Tokyo, JAPAN
TEL
0364172043
nobutaka.yagi@boehringer-ingelheim.com
Public contact
Name of contact person
| 1st name | Nobutaka |
| Middle name | |
| Last name | Yagi |
Organization
Nippon Boehringer Ingelheim Co., Ltd.
Division name
Patient Engagement
Zip code
141-6017
Address
2-1-1 Osaki, Shinagawa-ku,Tokyo, JAPAN
TEL
0364172043
Homepage URL
nobutaka.yagi@boehringer-ingelheim.com
Sponsor or person
Institute
Nippon Boehringer Ingelheim Co., Ltd.
Institute
Department
Personal name
Funding Source
Organization
Nippon Boehringer Ingelheim Co., Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Medical Corporation Kyoso-kai AMC Nishi-Umeda Clinic Ethics Review Committee
Address
Maruit Nishi-Umeda Building 3F, 3-3-45 Umeda, Kita-ku, Osaka-shi, Osaka, Japan
Tel
0647975660
morikawa@amc-clinic.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 07 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2022 | Year | 05 | Month | 19 | Day |
Date of IRB
| 2022 | Year | 05 | Month | 27 | Day |
Anticipated trial start date
| 2023 | Year | 02 | Month | 01 | Day |
Last follow-up date
| 2023 | Year | 08 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Non-interventional study
Management information
Registered date
| 2022 | Year | 06 | Month | 15 | Day |
Last modified on
| 2022 | Year | 12 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054566
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
